Autoimmune disease after alemtuzumab treatment for MS
Autoimmune disease after alemtuzumab treatment for MS
Summary: Alemtuzumab is a monoclonal antibody, which is a candidate treatment for MS. One of the potential side effects of this medication was the development of autoimmune disease.
In this study the authors prospectively analyse both clinical and serological data of patients with MS treated with alemtuzumab. It was found that autoimmune disease developed in 22.2% of those treated with a range of different systems affected, with thyroid autoimmune disease being seen most commonly (15.7%). It was found that sex and age did not have an influence on the frequency of disease; however smoking and a family history of autoimmune disease did increase its frequency.
This study provides information on the development of autoimmune disease, which could be presented to patients being counseled prior to treatment with alemtuzumab.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1680 Views
-
Last post by frodo
-
- 7 Replies
- 2391 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1428 Views
-
Last post by Tif
-
- 0 Replies
- 1788 Views
-
Last post by seeva
-
- 0 Replies
- 1654 Views
-
Last post by frodo
-
- 1 Replies
- 1264 Views
-
Last post by NHE
-
- 1 Replies
- 1582 Views
-
Last post by Leonard
-
- 0 Replies
- 2505 Views
-
Last post by NHE
-
- 0 Replies
- 713 Views
-
Last post by NHE